نتائج البحث - Sorbye, Halfdan
- يعرض 1 - 20 نتائج من 32
- اذهب إلى الاصفحة التالية
-
1
Survival According to Primary Tumor Location, Stage, and Treatment Patterns in Locoregional Gastroenteropancreatic High-grade Neuroendocrine Carcinomas حسب Dasari, Arvind, Shen, Chan, Devabhaktuni, Anjali, Nighot, Ruda, Sorbye, Halfdan
منشور في 2022نص -
2
-
3
Duodenogastric Reflux Increases the Penetration of N‐(3)H‐Methyl‐N‐nitro‐N‐nitrosoguanidine into the Antral Mucosa of Rats: A Possible Role for Mucosal Erosions and Increased Cell... حسب Øvrebø, Kjell K., Svanes, Knut, Aase, Steinar, Grong, Ketil, Sørbye, Halfdan
منشور في 2002نص -
4
Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours حسب Sorbye, Halfdan, Meyer, Liv Sylvi, Mordal, Kjersti Elisabeth, Myhre, Simen, Thiis-Evensen, Espen
منشور في 2020نص -
5
Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy f... حسب Winther, Stine Braendegaard, Österlund, Pia, Berglund, Åke, Glimelius, Bengt, Qvortrup, Camilla, Sorbye, Halfdan, Pfeiffer, Per
منشور في 2017نص -
6
-
7
Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases حسب Løes, Inger Marie, Immervoll, Heike, Sorbye, Halfdan, Angelsen, Jon‐Helge, Horn, Arild, Knappskog, Stian, Lønning, Per Eystein
منشور في 2016نص -
8
-
9
High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer حسب Siesing, Christina, Sorbye, Halfdan, Dragomir, Anca, Pfeiffer, Per, Qvortrup, Camilla, Pontén, Fredrik, Jirström, Karin, Glimelius, Bengt, Eberhard, Jakob
منشور في 2017نص -
10
CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup حسب Aasebø, Kristine, Dragomir, Anca, Sundström, Magnus, Mezheyeuski, Artur, Edqvist, Per-Henrik, Eide, Geir Egil, Ponten, Fredrik, Pfeiffer, Per, Glimelius, Bengt, Sorbye, Halfdan
منشور في 2020نص -
11
High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Met... حسب Sorbye, Halfdan, Dragomir, Anca, Sundström, Magnus, Pfeiffer, Per, Thunberg, Ulf, Bergfors, Monica, Aasebø, Kristine, Eide, Geir Egil, Ponten, Fredrik, Qvortrup, Camilla, Glimelius, Bengt
منشور في 2015نص -
12
Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre rando... حسب Labori, Knut Jørgen, Lassen, Kristoffer, Hoem, Dag, Grønbech, Jon Erik, Søreide, Jon Arne, Mortensen, Kim, Smaaland, Rune, Sorbye, Halfdan, Verbeke, Caroline, Dueland, Svein
منشور في 2017نص -
13
Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients حسب Aasebø, Kristine Ø., Dragomir, Anca, Sundström, Magnus, Mezheyeuski, Artur, Edqvist, Per‐Henrik, Eide, Geir Egil, Ponten, Fredrik, Pfeiffer, Per, Glimelius, Bengt, Sorbye, Halfdan
منشور في 2019نص -
14
Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients حسب Aasebø, Kristine, Bruun, Jarle, Bergsland, Christian H., Nunes, Luís, Eide, Geir Egil, Pfeiffer, Per, Dahl, Olav, Glimelius, Bengt, Lothe, Ragnhild A., Sorbye, Halfdan
منشور في 2021نص -
15
Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study حسب Tarpgaard, Line S., Guren, Tormod K., Glimelius, Bengt, Christensen, Ib J., Pfeiffer, Per, Kure, Elin H., Sorbye, Halfdan, Ikdahl, Tone, Yilmaz, Mette, Johansen, Julia S., Tveit, Kjell Magne
منشور في 2014نص -
16
Let-7 miRNA-binding site polymorphism in the KRAS 3(′)UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorecta... حسب Kjersem, Janne B, Ikdahl, Tone, Guren, Tormod, Skovlund, Eva, Sorbye, Halfdan, Hamfjord, Julian, Pfeiffer, Per, Glimelius, Bengt, Kersten, Christian, Solvang, Hiroko, Tveit, Kjell M, Kure, Elin H
منشور في 2012نص -
17
Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer حسب Thomsen, Maria, Kersten, Christian, Sorbye, Halfdan, Skovlund, Eva, Glimelius, Bengt, Pfeiffer, Per, Johansen, Julia S., Kure, Elin H., Ikdahl, Tone, Tveit, Kjell Magne, Christoffersen, Thoralf, Guren, Tormod Kyrre
منشور في 2016نص -
18
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome حسب Thomsen, Maria, Skovlund, Eva, Sorbye, Halfdan, Bolstad, Nils, Nustad, Kjell Johannes, Glimelius, Bengt, Pfeiffer, Per, Kure, Elin H., Johansen, Julia S., Tveit, Kjell Magne, Christoffersen, Thoralf, Guren, Tormod Kyrre
منشور في 2018نص -
19
Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3) حسب Ali, Abir Salwa, Grönberg, Malin, Langer, Seppo W., Ladekarl, Morten, Hjortland, Geir Olav, Vestermark, Lene Weber, Österlund, Pia, Welin, Staffan, Grønbæk, Henning, Knigge, Ulrich, Sorbye, Halfdan, Janson, Eva Tiensuu
منشور في 2018نص -
20
Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study حسب Guren, Tormod Kyrre, Thomsen, Maria, Kure, Elin H, Sorbye, Halfdan, Glimelius, Bengt, Pfeiffer, Per, Österlund, Pia, Sigurdsson, Fridbjörn, Lothe, Inger Marie Bowitz, Dalsgaard, Astrid Marie, Skovlund, Eva, Christoffersen, Thoralf, Tveit, Kjell Magne
منشور في 2017نص